UTokyo IPC Invests in CORE Biomedicine, Inc.

UTokyo Innovation Platform Co., Ltd. (UTokyo IPC; President & CEO: Kosuke Ueda) announced today that its Accelerating Open Innovation 1 Investment Limited Partnership (AOI Fund I) has established and invested in CORE Biomedicine, Inc. (CORE Biomedicine; CEO: Ping Zhu, Ph.D.), a biotech startup based in Cambridge, Massachusetts, dedicated to innovative oncology drug development.

“We are excited to support CORE Biomedicine in its mission to advance innovative therapeutics by leveraging cutting-edge research from the University of Tokyo and other leading institutions,” said Makoto (Mark) Ohori, Ph.D., Partner and Chief Investment Officer, Life Sciences at UTokyo IPC. “This investment represents a significant milestone in fostering global biotechnology innovation, and we look forward to CORE Biomedicine’s impact in the oncology space.”

AOI Fund I: Accelerating Open Innovation in Japan

Launched in 2020, AOI Fund I was established with the objective of fostering open innovation activities around the University of Tokyo. The fund operates under the concept of “nurturing and investing in startups through corporate-academia collaboration.” By supporting the formation of new ventures in collaboration with industry leaders, investing in corporate spin-outs, and facilitating the effective utilization of corporate assets, AOI Fund I seeks to create successful case studies of open innovation across diverse industries.

About UTokyo IPC

UTokyo IPC is an investment company dedicated to advancing the academic startup ecosystem. Alongside investments in over 75 university-affiliated startups worldwide, UTokyo IPC provides hands-on support, talent development, and operates “1stRound,” one of Japan’s largest accelerator programs, co-hosted by 22 academic institutions. By fostering collaborations among academia, corporations, venture capital firms, and government entities, UTokyo IPC aims to enhance Japan’s global industrial competitiveness through the creation of world-class startups and ecosystem development.

Company Overview

Business: Investment company focused on academic startup ecosystem development
Founded: January 2016
Shareholder: The University of Tokyo (100%)
Headquarters: Entrepreneur Lab 261, South Research Building, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
President & CEO: Kosuke Ueda
Website: https://www.utokyo-ipc.co.jp/

Contact

UTokyo Innovation Platform Co., Ltd.
Entrepreneur Lab 261, South Research Building, The University of Tokyo
7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
TEL: +81-3-3830-0200 / FAX: +81-3-3830-0183
Email: info2@utokyo-ipc.co.jp
Contact: Makoto (Mark) Ohori, Atsuhiro Bingo